Covered recipient · General Payments record
NIKHIL BALAKRISHNAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$2,672.69
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $711.73 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $116.51 | 1 |
| MDD US Operations, LLC | $88.19 | 4 |
| EISAI INC. | $86.02 | 2 |
| Lilly USA, LLC | $70.16 | 4 |
| ARGENX US, INC. | $69.32 | 3 |
| Biogen, Inc. | $53.23 | 3 |
| PFIZER INC. | $37.11 | 2 |
| CSL Behring | $36.36 | 2 |
| Aucta Pharmaceuticals, Inc. | $31.88 | 2 |
| UCB, Inc. | $22.73 | 1 |
| SCILEX PHARMACEUTICALS INC. | $19.82 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.02 | 1 |
| Celgene Corporation | $16.63 | 1 |
| Novo Nordisk AS | $16.17 | 1 |
| Neurelis, Inc. | $15.58 | 1 |
| ABBVIE INC. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.00 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103270373 | CMS |
| ARGENX US, INC. | $23.97 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142106976 | CMS |
| ARGENX US, INC. | $20.56 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142110239 | CMS |
| ARGENX US, INC. | $24.79 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142119365 | CMS |
| Aucta Pharmaceuticals, Inc. | $16.29 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147905974 | CMS |
| Aucta Pharmaceuticals, Inc. | $15.59 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147907032 | CMS |
| Biogen, Inc. | $22.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104866082 | CMS |
| Biogen, Inc. | $13.73 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104830312 | CMS |
| Biogen, Inc. | $17.50 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104860316 | CMS |
| Celgene Corporation | $16.63 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101088485 | CMS |
| CSL Behring | $21.72 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134616663 | CMS |
| CSL Behring | $14.64 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134616689 | CMS |
| Eisai Inc. | $61.34 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110770315 | CMS |
| Eisai Inc. | $24.68 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110770317 | CMS |
| Lilly USA, LLC | $17.85 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135256894 | CMS |
| Lilly USA, LLC | $17.32 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135247247 | CMS |
| Lilly USA, LLC | $18.28 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135256899 | CMS |
| Lilly USA, LLC | $16.71 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135256891 | CMS |
| MDD US Operations, LLC | $25.14 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147749112 | CMS |
| MDD US Operations, LLC | $19.82 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748996 | CMS |
| MDD US Operations, LLC | $21.60 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147748998 | CMS |
| MDD US Operations, LLC | $21.63 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147749110 | CMS |
| Neurelis, Inc. | $15.58 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632849 | CMS |
| Novo Nordisk Inc | $16.17 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097680642 | CMS |
| PFIZER INC. | $21.22 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131763124 | CMS |
| PFIZER INC. | $15.89 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131876737 | CMS |
| SCILEX PHARMACEUTICALS INC. | $19.82 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136278128 | CMS |
| Supernus Pharmaceuticals, Inc. | $116.51 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147846436 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.02 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137479254 | CMS |
| UCB, Inc. | $22.73 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143042297 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.